This one appears to have more fluff than my duvet
Printable View
This one appears to have more fluff than my duvet
Looks like some of the PHD students are helping Blis with research.
I wonder how that works?
I think from memory Blis has rights of Blis science
for 10 years from Otago Uni.
That was a few years ago though
http://microbiology.otago.ac.nz/dept.../profiles.html
Hopefully we get some exciting news in the next couple of
weeks to make the rights issue succed.
Numero uno
Research followed by enough money to pay management, what are shareholders for but to provide a means to an end in this case more research.
Understand your cynicism, Impatient, as there have many overly optimistic (i.e. BS) forecasts in the past. I think there has been a real change of tone under Barry and I expect to see confirmation in the half-year results that this latest forecast is reasonable. Barry has taken his fees (so far) in BLT shares, and will now need to put in his own cash to take up his rights entitlement - it's ridiculous to suggest he is guilty of trying to soak BLT shareholders.
The half-year announcement is now late - BLT lose all credibility if this doesn't come out well before the rights offer closes, so I'm guessing they are waiting to announce some sort of deal - hopefully something that will motivate uptake of the rights, as there doesn't appear to be much point at the moment. Thinking of taking a punt on some rights at 0.1 cents - if nothing comes of it then not much to lose, but plenty of potential on the upside.
Just received my RI papers in the mail. FYI overseas holders have until 30 Nov to respond with cash and application. After that date the rights of overseas holders will be force-sold on-market and the proceeds sent to them. So maybe expect a few more sales next week at 1cps ...although not many non-NZ addressed holders I expect.
I have just posted off the chq subscribing in full
to the rights issue.
Will be interesting to see who the global companys are?
Hopefuly the "near future" is soon
Anyone else here subscribing?
It should be interesting to see how much they raise
and who subscribes.
Ya never know ya luck in the big city.
Oman bought all his rights and will pick up a few more on-market later.
Some self fulfilling prophecy in this exercise ...if holders provide the cash they help make BLT a success ...but the reverse occurs if they don't. Ummm, I wonder which way those 2-3 main shareholders will lean?
I thought Barry would try to persuade the market to support BLT more than he did in the half year report ...but then, why bother if no one's listening to what's already been clearly stated? ...and maybe there's a Plan B in the shadows as unsubscribed rights can be parcelled and sold if I read the prospectus correctly ...and there might be a buyer looking for that parcel.
Thats great Oman Im not the only one! ha ha
Thats very true, I hope they raise some decent cash.
Reading between the lines looks like they thought they
could announce something but the timing was off.
I got a reminder notice in the mail, loks like the directors
are taking up their rights.
Hopefully Barry is taking up his, even better if the university is!
Yeah, scamper's in too.
got a letter last week saying that all the directors, and fennessy, are taking up their full allocations. fingers crossed.
Have finally decided to support it. Like T1, I reckon they're close to announcing something "biggish", but the timing hasn't worked out. I was a bit disappointed in the half-year result, but Barry has accomplished a lot in his short time at the helm, and I trust him to deliver on the breakeven forecast, given that it has been repeated in the latest announcement.
I'm in too; cheque's in the mail ;-) Really.
after the half decade of support i put into this company, i want to see real evidence of growth before i cough up more cash.
maybe the rights issue should have a time held discount attached to them, that way folks like me that forked out $1 per share and supported the coy at the beginning can get a little reward.
i have since averaged down to 20c per share, to chuck more cash at this coy at this stage even at this low price is going to hurt.
Oh wow, there hasnt been a post here for ages - what's happening? No news? No comments on how awesome this company is?.......thought so!
Just under $1.4 million raised through the rights issue, with just under 41% of rights taken up. I thought they'd not even make it to 30%. 41% is pretty bad, but falls short of a complete disaster. It'll be interesting to see how successful they are at marketing the shortfall.
I think the BLT team were expecting a 50% acceptance and there was a contingency plan for the remainder. The question now is, who is the possible buyer of such a large parcel?
I know its not me, but I did take up my options hopefully I've done the right thing its funny how a few companies (PEB on NZX, and MRX on ASX)have come back to shareholders for money at Xmas with a short time frame to stump up with the cash its almost as if they are giving you an option but dont want you to take them up on the offer, Xmas is renowned for being a bad time to sell shares on the open market,
I also wondered about the public face ...like going through the correct protocols ...and the real deals done in private. I hope we aren't being sold off too cheaply to a big fish ...but then, when I think about it, a big fish could be useful compay to have now ...providing it's not a shark :)
At the price of todays shares I would say its already sold off at bargain basement, if a big company wants in now is when its gonna happen if not blow it a kiss.
So one man has confidence in BLT. 7m shares held by Michael Bird and probably more announcements to come over the next week or so. The picture should be clear by end Jan.
It's Feb and the picture is clear enough ...the big holders didn't support the rights issue ...the SP is dropping as disillusionment increases among the doubters. Perhaps there’ll be some positive news before Easter.
In case you hadn't noticed Oman, there's been quite a lot of turmoil on the markets. The amazing thing is that this shareprice has barely moved. I would have expected a little biotech like this to be dropped like a hot potato, but I guess when you're only talking about a share worth a few cents, there's not that much further to go.
Like I said earlier blow it a kiss and watch it float off,downwards.Blis are a long way off making any money for long suffering shareholders they don't care about you they floated this to get the chance to do more research you are way down the list.
It could be that no news is good news?
Yeah hopefuly no news is good news, wishful thinking though
Hopefuly we get an annoucement soon.
What intrigues me is the talk about the discussions
with big multinationals, they said a few months ago
they expect to make an announcment in the near future.
Surely this must be something to do with the dental caries
product. They talk about wanting to deal with the top 3 companies in
the market.
Hopefuly thats colgate or macleans that would be awesome!
My guess is Japanese pharmaceutical must be a small company as they havent stated the
size and they have had the deal for a long time.
If DSM was going to take up 19% of the shares would it take this long?
What gives me confidence is Barry Richardson has at least 3 million shares, so he
is doing the best he can!
So far he has done a great job.
Bobby the Blis research expert it would be great to hear your views!
BLIS has a history of minimal news releases but steady effort. Barry will be working on that 'to do' list above. He has already tried to dampen expectations by saying that these contractual discussions and agreements take time to work through.
I’m fairly sure BLT will have some positive news for the next FY report due about April. They have a 2-month window to work in ...which is actually rather tight.
I think the 7m is a combination of shares previously held + the 2:7 issue which has taken Mike over the 5% limit so he has to declare his name & the total holding. If this is correct then BLT still has 26m to find a buyer for at 7.5 cps ...which given the present market ...and without some 'SP boosting' news ...will be quite a challenge. If they don't raise that additional cash they may have problems funding the FDA food additive approval and other initiatives already announced.
Hi Simla. I checked the last annual report and Mike was holding 5m then so the extra 2m is from the issue.
Good to hear Pharmabroker are working on the BLT products. It sounds like they are looking at the product packaging from the customer's perspective. About time too. The present BLT labeling looks highly suitable for rat poison but not for health promotion products.
It's a pity BLT doesn’t have a logo like Intel …something like “Contains K12 inside”. Barry may need to think of the branding issue sometime soon ...if he's not already overloaded with so many other thoughts!
...actually it's a BIFF-IT. Where does the share price stand now, 5-6 cents???? HAHAHAHAHA, gosh if I wasn't losing a lot of money on it, I could only laugh at the naive optimism I still hear in his forum. I know that 'hope dies last', but come on, this is beyond wishful thinking and hope - its madness. There is NO news - HOW do we even know that Barry is doing anything rather than racking up expenses and costing us money??? It's not like he's actually keeping his head down, working away quietly and underpromising as a rule; recall the BIG BIG promises in AGM August 2007??? That came from the board AND from Barry's direction.
Back then the team rejected the idea of new directors that could have added some new ideas and, in particular, marketing expertise, so their products still look like crap, their marketing is non-existent, and to believe that Pharmabroker's "Yes, we're taking Blis seriously" is anything but a standard reply to a customer/investor inquiry is plain and simply naive, sorry. Call me persistently begative and pessimistic, but - like for the past years and years - I am still waiting for a change and nothing, I repeat NOTHING is happening.
For a board and CEO so arrogant as to not bother with keeping us investors - and we are effectively THEIR employers - up to date is disgusting. These people must go.
...tend to agree with you Impatient ...and with Scuffer. The present SP…no sales ...and the few buyers offering a pittance reflects the lack of information the Market has. I’m an optimist but I need the FY accounts to get a handle on the real BLT reality (assuming they don’t cook the books). :(
Hey Smila just found this patent application
for Q24 its very interesting
Regarding Probiotic deodorant
These results confirm the earlier assessment that Q24 is effective in reducing body odour. This is believed to be by action against the aerobic diphtheroids commonly implicated in body odour.
Effect of M luteus Q24 on Athlete's Foot
Formulation:
Grapeseed oil 2.O g
Chamomile oil 0.06 g
Q24 freeze-dried powder 0.1 g
The oil formulation was prepared by mixing M. luteus freeze-dried powder with the oils to produce a suspension formulation.
The Q24 cell count for the deodorant stick was 1.2 x 107 cfu/g.
The formulation was applied to the infected area of five subjects with athlete's foot daily for three days. Within 10 minutes the itchy symptoms had disappeared. After three days no further application was required due to cessation of the signs of infection.
All references including patents and publications cited in this specification are incorporated herein by reference
Http://www.wipo.int/pctdb/en/wo.jsp?...3&DISPLAY=DESC
Yeah, that's one of the strange things about Blis. They often refer to having other intellectual property that they can't tell us about. I suppose this could be part of that. Well done for finding that, by the way. But they also say that they can't run with ideas that won't make a profit. They said that bad breath is already serviced by other products, for example, so there is a limit to how far Blis can make inroads there, for example.
On the face of it, the athlete's foot is really a saleable product. We've all had athlete's foot at some time in our lives, and it's a nuisance. The cream you put on is meant to go on for up to two weeks after the infection is gone, which is a real nuisance too. So this would seem much better. Are they not running with this because they feel it is too hard to break an existing market? Or no money? Or perhaps they are trying to develop it and not saying?
You can see why not telling the whole world about their future is a reasonable plan. But it sure makes it hard for shareholders. Basically, the share price just goes down because there is no actual profit reported. Until there is, the share price is just a random number anyway and always will be. If there was profit, we would be more accepting of these various mysteries around the company.
Barry has several times said he expects to break even by March 31, presumably on an ongoing basis rather than Financial Year to March 2008. But of course, they do not have to tell us anything for three more months yet! Impatient, I'm not sure that Barry doesn't actually just keep his head down and promise little. He came out loudly when they needed to raise money, as is basically his job. But otherwise we do not hear a lot except announcements of actual events?
Certainly 2008 seems a make or break year for Blis. With some money under their belt, some talent accumulating in the office, and international contracts forming, things are never going to get better for finally making a profit.
Following the link and using the data about the 17172 bio strain took me to Yale University and Taiwan. I suspect this is the work of competitors rather than BLIS.
That's another worry for BLT investors ...the seemingly slow marketing of decent products. Being first to market is a competitive advantage so why does BLT allow Pharmabroker to take so long to produce results? Is it inertia ...or are they really trying to beat the opposition who are working in the same field and trying to market similar products?
I think we may have an element of town and gown. The PhDs of BLT may be a wee bit out of touch with commercial reality.
Go to:
http://www.wipo.int/pctdb/en/
and put in
Blis Technologies Limited
in the applicant name box and will be able to see for yourself which patents Blis has filed.
For me, knowing that Barry has more than a dozen times the number of Blis shares I do comforts me. He wouldn't have taken the job if he didn't think he could make a big difference and he sure as heck wouldn't have taken pay in the form of shares if he didn't see huge potential.
Patience is required with companies like this.
Thanks for the info Emearg.
The 17172 I tracked is already registered and the stuff is available off the shelf. The BLT claim involved 17172 but is a composition. Publication Number WO/2006/104403 SKIN TREATMENT COMPOSITIONS at the site Emearg provided above.
There is another patent for a BLIS treatment of acne but it's not registered as a BLT invention. The Publication Number is WO/2007/070518,
Oman, are you saying the Q24 treatment for athletes foot can be purchased at a chemist? My wife's a doctor, and some of her patients would probably like to try that.
As the patent seemed to suggest it had other uses, is athletes foot what it is sold for? And if it is for sale, are you saying that Blis are the ones selling it?
No Q24 isn't available at retail level but is at manufactuer's level ...if they have a licence to buy. The 17172 strain is held in a German bio-stockbank as far as I can see. BLT could get it okay but we can't.
ps. 1% Nizoral is good for the foot problem.
Thanks! Medical advice included here huh?
:) no advice intended ...just a sudden thought as a PS.
There are already effective cures for fungal attacks so how will BLT convince doctors/buyers that their hypothetical Q24 product has additional benefits that will cause them to change their habitual treatment? Can they overcome the 'established market inertia factor'?
I just noticed that therabreath has started selling K12 as a gum and also as a lozenge.
I assume they now they have approval to sell as a Lozenge in USA which is great news.
Before they could only sell as mouthwash.
http://www.therabreath.com/product.asp?CAT=22
Hopefuly we will hear about the major nutraceutical company selling in USA soon, maybe they will be selling as a lozenge?
Well spotted again, THEONE. You may be right that this will lead to further developments in the shorter term. Blis have been talking of gum for some time I think. And Pharmabroker talked of a user-friendly product. Gum and lozenges would seem to fit that description pretty well. Certainly chewing gum for bad breath or a sore throat is the sort of thing consumers can probably relate to pretty easily. Same for lozenges.
Not sure about the American neutraceutical company selling lozenges though. Does anyone feel they are sure just quite what neutraceutical means? Google says it is a healthy additive to food, which is more like what Nestle are looking at. It would sort of seem to require you to be a food company wouldn't it?
To answer my own question for anyone who cares, after looking around the net neutraceuticals seems to mean biological-based additives to food. Half of them seem to fall into the Blis category - ie. tested - and half them are just fad claims. So they seem to be growing in popularity as part of the "green" revolution. Perhaps it is that aspect which makes Blis attractive to some of us?
Incidentally, for anyone interested, while looking I came across this NZ government list of Blis-like companies in NZ in 2005. It includes a lot of companies I had never heard of, although lots seem to be privately owned. If anyone finds any good investments here though, let us know ...
http://www.ableindia.org/images/biotech_nz_reduced .ppt
The desk reshuffle announced today shows that we were right about the BLT PhDs being focused on research instead of commercial profits. Murray Kennedy probably worked with Barry previously so his track record will be a good one.
Wonder if Blis will get a slice of the new Govt. "innovation" funding package being announced tomorrow? Food ingredients was mentioned on the news as one of the areas being targeted.
Would you employ a mechanic to come round and rewire your house, these guys are not the best men for the job.
An Exec MBA takes 1 year plus a 3-month thesis. You start learning about business reality after another year on the job. So do we have another delay to profitability here?:(
"It is very obvious to me from our ongoing relationship with companies such as Nestle Nutrition and others who can't be named right now, that we need staff who not only understand our unique science, but who can also understand its commercial value and can negotiate future contracts on that basis,... It is all about having people who can convert our intellectual assets into commercial reality"
I wonder who are the others who can't be named right now are?
I am glad to see these guys taking up their rights! It is nice not to be the only one backing the future of this company. Barry has serious amounts of money invested in it becoming a success.
BLIS Technologies Limited BLT 19 Mar, 2008, 14:51 RELINT Disclosure of Directors and Officers Relevant Interests
Full Text of Announcement
DISCLOSURE NOTICE
Disclosure of Directors and Officers Relevant Interests
(Section 19T, Securities Markets Act 1988)
A. Disclosure obligation (tick box to note which disclosure obligation applies)
Initial disclosure (complete Parts A, B, C, D, F, and G of this notice)
Ongoing disclosure (complete Parts A, B, C, E, F and G of this notice) X
B. Preliminary
1. Name Peter Francis Fennessey
2. Name of issuer BLIS Technologies Limited
NZX company code of issuer BLT
3. Name of related body corporate (if applicable) N/a
4. Position you hold in the issuer or related body corporate Chairman & Director
5. Date of this disclosure notice 19-Mar-08
C. Nature of relevant interest
6. Name of registered holder(s) of security (as required by regulation 6A(b) or regulation 7(b)) Peter Francis Fennessey
7. Class and type of security (as required by regulation 6B or regulation 8) Ordinary shares
8. Nature of relevant interest in security (as required by regulation 6A (a) or regulation 7(a)) Beneficial owner
D. Date (for initial disclosure)
9. Date of disclosure obligation (as required by regulation 6C) N/a
E. Transaction (for ongoing disclosure)
10. Date of last disclosure (as required by regulation 13) 14.12.2007
11. Date(s) of acquisition(s) or disposal(s) (as required by regulation 9)
12. Number of transactions (as required by regulation 12(2), if applicable) N/a
13. Nature or type of transaction (as required by regulation 11(1)(a)) Acquisition of ordinary shares pursuant to 2 for 5 renounceable rights issue
14. Consideration (as required by regulation 10) 7.5 cents per ordinary shares (in aggregate $11,910)
15. Number of securities held prior, set out by class and type (as required by regulation 8) 147,000 ordinary shares
16. Number of securities subject to acquisition or disposal (as required by regulation 11(1)(b)) 158,800 ordinary shares
F. Extent of relevant interest
17. Number of securities held now, set out by class and type (as required by regulation 6B or regulation 8) 305,800 ordinary shares
Signature (as required by regulation 14)
DISCLOSURE NOTICE
Disclosure of Directors and Officers Relevant Interests
(Section 19T, Securities Markets Act 1988)
A. Disclosure obligation (tick box to note which disclosure obligation applies)
Initial disclosure (complete Parts A, B, C, D, F, and G of this notice)
Ongoing disclosure (complete Parts A, B, C, E, F and G of this notice) X
B. Preliminary
1. Name Colin Ernest Dawson
2. Name of issuer BLIS Technologies Limited
NZX company code of issuer BLT
3. Name of related body corporate (if applicable) N/a
4. Position you hold in the issuer or related body corporate Director
5. Date of this disclosure notice 18-Mar-08
C. Nature of relevant interest
6. Name of registered holder(s) of security (as required by regulation 6A(b) or regulation 7(b)) Colin Ernest Dawson
7. Class and type of security (as required by regulation 6B or regulation 8) Ordinary shares
8. Nature of relevant interest in security (as required by regulation 6A (a) or regulation 7(a)) Beneficial owner
D. Date (for initial disclosure)
9. Date of disclosure obligation (as required by regulation 6C) N/a
E. Transaction (for ongoing disclosure)
10. Date of last disclosure (as required by regulation 13) 14.12.2007
11. Date(s) of acquisition(s) or disposal(s) (as required by regulation 9)
12. Number of transactions (as required by regulation 12(2), if applicable) N/a
13. Nature or type of transaction (as required by regulation 11(1)(a)) Acquisition of ordinary shares pursuant to 2 for 5 renounceable rights issue
14. Consideration (as required by regulation 10) 0.07125 cents per ordinary share (in aggregate $28,500)
15. Number of securities held prior, set out by class and type (as required by regulation 8) 35,700 ordinary shares
16. Number of securities subject to acquisition or disposal (as required by regulation 11(1)(b)) 400,000 ordinary shares
F. Extent of relevant interest
17. Number of securities held now, set out by class and type (as required by regulation 6B or regulation 8) 435,700 ordinary shares
Signature (as required by regulation 14)
DISCLOSURE NOTICE
Disclosure of Directors and Officers Relevant Interests
(Section 19T, Securities Markets Act 1988)
A. Disclosure obligation (tick box to note which disclosure obligation applies)
Initial disclosure (complete Parts A, B, C, D, F, and G of this notice)
Ongoing disclosure (complete Parts A, B, C, E, F and G of this notice) X
B. Preliminary
1. Name Maxwell Gilbert Shepherd
2. Name of issuer BLIS Technologies Limited
NZX company code of issuer BLT
3. Name of related body corporate (if applicable) N/a
4. Position you hold in the issuer or related body corporate Director
5. Date of this disclosure notice 18-Mar-08
C. Nature of relevant interest
6. Name of registered holder(s) of security (as required by regulation 6A(b) or regulation 7(b)) (i) Maxwell Gilbert Shepherd and Cheung-Tak Hung as trustees of the Rutherglen Trust; (ii) M G & L A Shepherd Family Trust
7. Class and type of security (as required by regulation 6B or regulation 8) Ordinary shares
8. Nature of relevant interest in security (as required by regulation 6A (a) or regulation 7(a)) (i) Non-beneficial; (ii) Beneficial owner
D. Date (for initial disclosure)
9. Date of disclosure obligation (as required by regulation 6C) N/a
E. Transaction (for ongoing disclosure)
10. Date of last disclosure (as required by regulation 13) 14.12.2007
11. Date(s) of acquisition(s) or disposal(s) (as required by regulation 9)
12. Number of transactions (as required by regulation 12(2), if applicable) N/a
13. Nature or type of transaction (as required by regulation 11(1)(a)) Acquisition of ordinary shares pursuant to 2 for 5 renounceable rights issue
14. Consideration (as required by regulation 10) 7.5 cents per ordinary share (in aggregate $24,382.50)
15. Number of securities held prior, set out by class and type (as required by regulation 8) (i) 2,287,671 ordinary shares; (ii) 812,750 ordinary shares
16. Number of securities subject to acquisition or disposal (as required by regulation 11(1)(b)) 325,100 ordinary shares
F. Extent of relevant interest
17. Number of securities held now, set out by class and type (as required by regulation 6B or regulation 8) (i) 2,287,671 ordinary shares; (ii) 1,137,850 ordinary shares
Signature (as required by regulation 14)
DISCLOSURE NOTICE
Disclosure of Directors and Officers Relevant Interests
(Section 19T, Securities Markets Act 1988)
A. Disclosure obligation (tick box to note which disclosure obligation applies)
Initial disclosure (complete Parts A, B, C, D, F, and G of this notice)
Ongoing disclosure (complete Parts A, B, C, E, F and G of this notice) X
B. Preliminary
1. Name Barry Charles Richardson
2. Name of issuer BLIS Technologies Limited
NZX company code of issuer BLT
3. Name of related body corporate (if applicable) N/a
4. Position you hold in the issuer or related body corporate CEO (pursuant to a contract for services with Barry Richardson Enterprises Limited
5. Date of this disclosure notice 18-Mar-08
C. Nature of relevant interest
6. Name of registered holder(s) of security (as required by regulation 6A(b) or regulation 7(b)) (i) Barry Charles Richardson & Joy Vera Richardson; (ii) Barry Richardson Enterprises Limited
7. Class and type of security (as required by regulation 6B or regulation 8) Ordinary Shares
8. Nature of relevant interest in security (as required by regulation 6A (a) or regulation 7(a)) Beneficial owner
D. Date (for initial disclosure)
9. Date of disclosure obligation (as required by regulation 6C) N/a
E. Transaction (for ongoing disclosure)
10. Date of last disclosure (as required by regulation 13) 3-Apr-07
11. Date(s) of acquisition(s) or disposal(s) (as required by regulation 9)
12. Number of transactions (as required by regulation 12(2), if applicable) N/a
13. Nature or type of transaction (as required by regulation 11(1)(a)) Acquisition of shares pursuant to 2 for 5 renounceable rights issue
14. Consideration (as required by regulation 10) (i) 7.5 cents per ordinary share (in aggregate $30,000); (ii) 7.5 cents per ordinary share (in aggregate $90,000)
15. Number of securities held prior, set out by class and type (as required by regulation 8) (i) 1,000,000 ordinary shares; (ii) 3,000,000 ordinary shares
16. Number of securities subject to acquisition or disposal (as required by regulation 11(1)(b)) (i) 400,000 ordinary shares; (ii) 1,200,000 ordinary shares
F. Extent of relevant interest
17. Number of securities held now, set out by class and type (as required by regulation 6B or regulation 8) (i) 1,400,000 ordinary shares; (ii) 4,200,000 ordinary shares
Signature (as required by regulation 14)
So they managed to flog off another 1.5m shares from the unsold rights raising about $100,000. Not exactly a rush of buyers ...but in the present financial climate, quite a good achievement.
About those unnamed companies ...we know Barry wants BLT to be in the branded food ingredients market so the clue probably lies in there somewhere. Can't be many big names in the food mixing business. :)
Umm ...if they were so committed and of the opinion that BLT is a super-winner why didn't they grab those 25 million or so of unsubscribed rights?
No spare money? Maybe ...but it could also be they were just doing the minimum expected of directors. The RI milestone was just barely passed so if they hadn't supported it the issue may well have failed completely.
Let's hope the 19% shareholding goes ahead. That would be positive.
Wow, somebody bought blis shares for a whole $40!!! Somebody's betting big on the company.... :-)
I have heard word there is current unpublished research to suggest BLIS may not be as effective as first thought. Could be something to look into..
DISC I do not hold and have not followed BLT, just heard news from someone working on a similar project.
TVNZ had an Aussie health program on Sat morning.
Dr Spiser (sp?) was profiled with a probiotic product "from New Zealand". The demo, with two presenters, showed significant reduction in cysteine producing bacteria and hence a significant reduction in bad breath.
This is subjective anecdotal stuff …but I know five people (six if we include me) who have benefited from the K12 chewing gum formula. They all throw out the fresh breath pack fluids and just use the chewing gum as directed ...twice a day. It seems to help with ENT problem including allergy, sore throat, and sinus problems ...even helps with bad breath!
Well all I can say is the stuff works because I've seen the effects and the health benefits, anyone who disagrees go and buy some and use it or find someone who needs it and give it to them then wait for the positive reaction.
It works for me and my bad breath. I would be gutted if K12 was not on the market.
On that subject price is almost irrevant when it comes to bad breath.
I used to get three or four colds every winter. Was an absolute given. Two years ago I bought a bottle of the throat guard when I felt a sore throat brewing (once I got one I always got a cold in four - seven days). I didn't get a cold that year. Last year I did the same. Again no colds. For me that is a big change. Did Throat Guard do it? One can only wonder but this year when I feel a sore throat brewing I will be heading to the chemist. Interesting aye?!
I use one tablet at night occasionally if my teeth are "twinging" a bit. Seems to work.
Also, have found just one tablet at bedtime is enough for kids with sore throats to wake up cured. And for those persistent "don't-want-to-go-to-school-stomach-ache", I find one dose of Bio-restore seems to work. (Never sure whether that is the castor oil "no-don't-make-me-drink-that-stuff" effect, but seriously, who cares?) :cool:
I’m surprised to find BLT listed on the USA ‘Other the Counter’ (OTC) trading lists. BLTHF was listed 20 Mar 2008. FYI the links are:
http://www.otcbb.com/asp/Info_Center.asp
http://www.search.com/reference/Over...unter_(finance)
http://www2.barchart.com/lookup.asp?sym=BLI&code=BNAMC
http://www2.barchart.com/lookup.asp?...s=&code=BSQUSA
The HY report pointed to a DMS marketing agreement. We should hear about that soon …and the Ireland market roll out.
I like Barry …he thinks Big!
Oops typos ...should be 'Over the Counter' (OTC) ...& DSM Nutrition
I came across the new packageing on the internet
http://www.goo.net.nz/?goo=evidence&...=blis2&after=1
I wonder if they will step up the marketing this winter with the new packaging?
Anyways the Annual Report is due in around a month, hopefuly
we get some news then.
Its a bit of a worry about the Nutraceutical company in USA, they
were meant to start selling early 2008, I would have hoped we would have
heard something by now.
However the private placement of over $350K is encouraging.
Any ideas anyone?
Putting effort into the branding/ packaging should equal increased marketing. Still the oversea's markets are the big ones. Fingers crossed.
BLIS up 31% today on low volume
Just over a week to the annual result. If the forecast given at the time of the rights issue comes good then there ought to be a bit of upside in the SP. So a few punters getting in ahead of time perhaps?
30th May release moved out to 13th June and new accounting standard being implemented ...Umm. Personally I don't like delayed reports for whatever alleged reason.
Its a new way of accounting, nothing to be concerned about, a lot of other companies have been using the same waiver for compliance.
down to 4.5 cents on small volume...an indication of tomorrows report?
would the seller of $157-worth of shares be a likely soul for accurate prediction?
think not, but then, t'would be horrid if s/he was a lucky punter...
Ya have to look at the volume
When is the date for next report due
15:30 and still nothing. Not a happy omen, surely?
Loss for the second half only $57K. Sales rising. But still no evidence of progress on distribution/partnership arrangements portended earlier.
Loss of only $57k means this company can actually be profitable without the new developments, which is itself very reassuring. Especially with sales increasing fairly exponentially still.
Nestle deal proceeding to trials must mean they managed to do preliminary tests and also to install it into food successfully, which also is promising. Depends how effective it is after this presumably, for whether they go into production later.
Disappointing no signed deals on the various fronts, but they do not seem to have given up. No talk of the various shorter term deals, like the Irish chemist, though.
The usual "good news but we're still waiting" result? Although things are verging on profitable now, no matter what, it would appear.
"...The increasing complexities of the international regulatory environment have inhibited progress... "
That says it all really. No new Ireland/Spain rollout ...and nothing said about the USA sales. A marketing stuffup with Parmabroker ...and a FY loss down 30% on last year. Thats the positive bit ...the continuing trend towards profitability.
The capitalising of $567K means they are anticipating a continuing cashflow to cover the annual depreciation of that sum. In plain English, they are borrowing against future earnings to make today's accounts look good. :(
Hmm, I know takeover speculation (I should say HOPE) took place in this forum before but...I really wonder. Barry keeps indicating that huge chunks of Blis' anticipated revenue will come from ingredients and licensing. Now if this is really to become the multi-million dollar business as Barry promises, why wouldn't a multi-BILLION dollar giant like Nestle just gobble up Blis for the $8m it's currently 'worth'?? Somebody please explain that to a layperson like myself...I mean that money is pocket-change for Nestle,...less than pocket-change. So A) Nestle has very, very dumb managers who do not see the amazing opportunity to buy the goose that will lay their big, golden eggs, OR B) Nestle has very, very smart managers who can assess the potential value of this business much better than Barry + board and rather keep dealing with Blis at arm's length (...so far for the grand sum of $180k...certainly much less than what Barry + board are costing us).
The statement does not make clear if the capitalising is part of these figures yet, and yes, that could be massaging the figures significantly. But I still feel good about this, because sales of $657k is pretty solid stuff, especially being 41% up on last year. That looks real, and that means this company now has two futures. Yes, we want the current grand plans to come off, but this means the old original plan of profit out of sales direct to consumer is actually coming to pass after all. But it would be refreshing to get some plain, unambiguous, good news from Blis.
Impatient, you're dead right about the takeover point, of course. But don't the multinationals usually only buy the huge success stories, not speculative deals? Take the Microsoft bid for Yahoo, for example.
It is disapointing that their is no real mention about the international sales, in particular
in USA which was meant to start early 2008.
Hopefuly we will see sales in Ireland soon?, and Japan, Taiwan end of year.
It would have been good if they went into more detail, especially after last years
disapearing distributors.
I agree Simla it is very ambiguous, you need to read between the lines alot
If Blis realy wanted too i am sure they could easily start selling as a retail product internationaly, which makes me wonder what is happening behind the scenes.
As they have stated there goal is to sell as an ingredient to big multi national who buy in bulk.
If they didnt have any decent negotiations happening, i think they would have been
pushing their retail strategy more.
Other than that there are a few positives.
I wonder what are the odds of the Nestle trial being succesful?
It reminds me that most of blis costs are fixed and once sales increase,
Blis could be a very profitable company.
Hopefuly we will know more at the AGM, anyone going?
I probably will go
report like this dont know how the BLT share price going to react on monday
I think we have the answer to the above. The SP is 5 cps and there are almost no buyers. No surprises there.
The next milestone is the full report & accounts due 30 June, but I don't expect much interest in BLT until some substantial good news is produced ...that may take a few months yet ...did I hear the sceptics say '...a few years!'
Interesting bits in the report that I noticed:
- expanded agreement with Australian Breezecare.
- sales & marketing agreement with US Jack Klein & Associates, for multiple sales platforms in US
-other international research & development agreements being negotiated
- new marketing manager
- work done in Ireland (ambiguous!)
- several ingredient products in US before year end
- new products into NZ this month
- early sales of neutraceticals ingredients into US
- production scale launch in retail in US in August
-a fair amount of work internally as well, which will presumably pay off over time
Quite a bit to chew on. Sounds promising to me.
Have been chewing this over myself. Far more informative than the full year announcement to the market - hard to understand why they kept all this detail quiet - too busy geting on with the job, hopefully.
Very understated operations report - a deliberate contrast, I suspect, to previous years efforts which have been long on promises and short on delivery. Quoting from the report:
"BLIS Technologies received a production scale order for BLIS K12 which will likely launch in the US retail market in August 2008"
Something that in times past would have prompted a separate announcement - here it is barely a footnote.
Seems to be plently going on and a real sense of forward momentum. This report is one of the most positive I have seen ...
Ironically the SP is near all time lows.
Good point Oman. Blis is now doing everything that we've been waiting for. So if it does not work, if Blis really is not a very saleable product, then there really isn't anything else left to try. And the world collapsing is not exactly good timing. But on the other hand, actual cash sales of product last year, even without the neutraceutical route, were pretty healthy. With a bit of head wind, those sales might reach a million pa this year, which is probably enough for a company to get by on for a while failing all else.
Presume we will learn a little more at the AGM. I won't be there, so post anything interesting please anyone who is there. Has anyone seen anything of the promised relaunch in NZ this month?
But that would assume that we actually had a capable management team and board at Blis; if this product/company fails, don't blame the product or the economy - the product has amazing potential, it IS saleable. If it fails, it's entirely on the management's head, as other companies suffer the same economic conditions and startup difficulties and still prosper.
Don't get me wrong, I think it's great that from virtually zero activity in the 'pre-Barry' era we now have at least 'something' happening there, even though Barry & Co still cost us more than they earn us - that cannot be profitable business model, can it?
I think one thing needs to be clear here - first and foremost, Barry & Co see this company as a self-service money bank and take care of THEIR salaries; if there are any crumbs left for us shareholders, we'll get them. Yay.
Not sure if I can quite see it that way, Impatient! You can hardly expect them to work for years without a salary surely. We shareholders may not quite qualify for charitable status methinks!
Oh no, simla, don't misunderstand me. Of course I'm not expecting anybody to work for free; but whether the equivalent of $200k+ is appropriate for the CEO of a company that is haemorrhaging money is another question.
Ultimately we as shareholders are owed a decent return on investment, and with my money - our money as investors - getting gobbled up by staff costs, I see that payback moving further and further into the future....and perhaps never materialise if the company will have been bled dry. I think you get my drift.
...and let's not forget that they have had a FANTASTIC range of products for years (!) that they have been incapable of turning into a profit. I think that's what bugs myself and many other BLIS shareholders (especially the ones that got in early, unfortunately for them) the most. I'd assume you're not one of them as it would be perfectly natural to become...impatient.
Oh yes, I totally get the bit about getting in early. No, I wasn't there in those heady days. Really hard to say what the answer is about that. If nobody ever got in early, none of these companies would ever exist. Nevertheless, I still sense that (long years later) Blis is going to pay even that original investment back well. It's just a race now between Blis' rise and the world's collapse. If things were normal now, I think we would be very confident indeed about Blis' future. It is a bit like an Indiana Jones movie now - will our hero escape triumphant or will the mine collapse first?
This is the link to the Jack Klein marketing team in USA. They look pretty professional to me. If Barry is harnessing these sorts of people to drive BLT forward things may work out okay.
http://www.jawassociates.com/our_team.html
On another point the owner's equity in the accounts is padded. 1.1m of the 2.1m owner's equity is a nebulous tax credit that may never eventuate, and the 550k capitalisation derived from patents goodwill which again has no tangible value until someone buys in.
So we have a bit of wool over the eyes there but we also have some positive movements in the USA, a possible move in Ireland and some much improved product packaging in NZ.
On balance I think the SP is a tad on the low side ...not that anyone is buying any anyway.
I don't expect any cornerstone shareholder in the present climate. Maybe after they pass the break-even point. It looks like the Jack Klein input might be the tipping point for that.
The other guy, Grant Washington-Smith, may contribute more with the skin care products in the pipeline.
Do I understand that today the 28th the announcement is that the annual meeting is to be held 31st July and that proxy forms must be faxed by 11am tomorrow 29th?
The reason …the cynic might suggest is that somebody is standing for director who happens to be talking sense and asking all those questions that have appeared on this forum over the past year or so.
Do we now see the true colors of the BLT Board? They don’t want us to vote for change …do I smell a comfortable conservative Board with fascist leanings?
I hope everyone who attends the meeting votes for the man they DON’T want. It’s time to shake these people up a bit!